Literature DB >> 8704192

Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans.

T H Price1, G S Chatta, D C Dale.   

Abstract

Recombinant granulocyte colony-stimulating factor (G-CSF) was administered to healthy young (n = 32) and elderly (n = 19) volunteers (0 microgram/d, 30 microgram/d, or 300 microgram/d) to determine its effect on neutrophil production, blood kinetics, and tissue migration. Measurements included blood counts (daily), marrow neutrophil pool sizes and neutrophil tissue migration (baseline and day 5), blood kinetics (day 6), and marrow transit time while on drug (days 6 to 14). G-CSF markedly expanded the marrow neutrophil mitotic pool and shortened the transit time of the postmitotic pool (control, mean = 6.4 days; 300 microgram/d, mean = 2.9 d). G-CSF increased neutrophil production without significantly altering blood neutrophil half-life or margination. Compared to control, neutrophil accumulation in skin chambers decreased by about 50% in the 300 microgram/d group in both young and elderly subjects. G-CSF induced neutrophilia by stimulating proliferation of marrow neutrophil precursors and accelerating neutrophil entry into the blood. Decreased neutrophil inflammatory responses measured with the skin chamber technique may be because of the relative immaturity of the circulating cells or to alterations in neutrophil phenotype induced by G-CSF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8704192

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  65 in total

Review 1.  Mechanistic models for myelosuppression.

Authors:  Lena E Friberg; Mats O Karlsson
Journal:  Invest New Drugs       Date:  2003-05       Impact factor: 3.850

2.  A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation.

Authors:  Ivar Østby; Leiv S Rusten; Gunnar Kvalheim; Per Grøttum
Journal:  J Math Biol       Date:  2003-04-23       Impact factor: 2.259

3.  A simultaneous analysis of the time-course of leukocytes and neutrophils following docetaxel administration using a semi-mechanistic myelosuppression model.

Authors:  Angelica Linnea Quartino; Lena E Friberg; Mats O Karlsson
Journal:  Invest New Drugs       Date:  2010-12-14       Impact factor: 3.850

4.  Modelling human granulopoiesis under poly-chemotherapy with G-CSF support.

Authors:  M Scholz; C Engel; M Loeffler
Journal:  J Math Biol       Date:  2004-12-20       Impact factor: 2.259

5.  Semi-mechanistic model for neutropenia after high dose of chemotherapy in breast cancer patients.

Authors:  Amelia Ramon-Lopez; Ricardo Nalda-Molina; Belen Valenzuela; Juan Jose Perez-Ruixo
Journal:  Pharm Res       Date:  2009-06-02       Impact factor: 4.200

6.  CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions.

Authors:  Kyle J Eash; Jacquelyn M Means; Douglas W White; Daniel C Link
Journal:  Blood       Date:  2009-03-05       Impact factor: 22.113

Review 7.  Neutrophil biology and the next generation of myeloid growth factors.

Authors:  David C Dale
Journal:  J Natl Compr Canc Netw       Date:  2009-01       Impact factor: 11.908

Review 8.  The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.

Authors:  Der-Cherng Liang
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Population pharmacokinetic modelling of filgrastim in healthy adults following intravenous and subcutaneous administrations.

Authors:  Pawel Wiczling; Philip Lowe; Etienne Pigeolet; Frank Lüdicke; Sigrid Balser; Wojciech Krzyzanski
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

10.  Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor.

Authors:  David C Dale; Audrey Anna Bolyard; Tracy Marrero; Merideth L Kelley; Vahagn Makaryan; Emily Tran; Jamie Leung; Laurence A Boxer; Priya S Kishnani; Stephanie Austin; Corbinian Wanner; Iris A Ferrecchia; Dina Khalaf; Dawn Maze; Joanne Kurtzberg; Cornelia Zeidler; Karl Welte; David A Weinstein
Journal:  Curr Opin Hematol       Date:  2019-01       Impact factor: 3.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.